Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Boron neutron capture therapy may selectively kill tumor cells without harming
normal tissue.
PURPOSE: This phase I trial is studying the side effects and best dose of boron neutron
capture therapy following surgery in treating patients with glioblastoma multiforme removed
during surgery.
Phase:
Phase 1
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC